608 related articles for article (PubMed ID: 16291734)
1. Changes in the epidemiology of thalassemia in North America: a new minority disease.
Vichinsky EP; MacKlin EA; Waye JS; Lorey F; Olivieri NF
Pediatrics; 2005 Dec; 116(6):e818-25. PubMed ID: 16291734
[TBL] [Abstract][Full Text] [Related]
2. The changing profile of homozygous beta-thalassemia: demography, ethnicity, and age distribution of current North American patients and changes in two decades.
Pearson HA; Cohen AR; Giardina PJ; Kazazian HH
Pediatrics; 1996 Mar; 97(3):352-6. PubMed ID: 8604269
[TBL] [Abstract][Full Text] [Related]
3. Changing patterns of thalassemia worldwide.
Vichinsky EP
Ann N Y Acad Sci; 2005; 1054():18-24. PubMed ID: 16339647
[TBL] [Abstract][Full Text] [Related]
4. Genetic Blood Disorders Survey in the Sultanate of Oman.
Al-Riyami A; Ebrahim GJ
J Trop Pediatr; 2003 Jul; 49 Suppl 1():i1-20. PubMed ID: 12934793
[TBL] [Abstract][Full Text] [Related]
5. Phenotypes of individuals with a beta thal classical allele associated either with a beta thal silent allele or with alpha globin gene triplication.
Bianco I; Lerone M; Foglietta E; Deidda G; Cappabianca MP; Morlupi L; Ponzini D; Grisanti P; Di Biagio P; Amato A; Mezzabotta M; Graziani B
Haematologica; 1997; 82(5):513-25. PubMed ID: 9407714
[TBL] [Abstract][Full Text] [Related]
6. Identification of deletion and triple alpha-globin gene haplotypes in the Montreal beta-thalassemia screening program: implications for genetic medicine.
Akerman BR; Fujiwara TM; Lancaster GA; Morgan K; Scriver CR
Am J Med Genet; 1990 May; 36(1):76-84. PubMed ID: 2333910
[TBL] [Abstract][Full Text] [Related]
7. Molecular basis of thalassemia intermedia in Iran.
Akbari MT; Izadi P; Izadyar M; Kyriacou K; Kleanthous M
Hemoglobin; 2008; 32(5):462-70. PubMed ID: 18932071
[TBL] [Abstract][Full Text] [Related]
8. The clinical significance of the spectrum of interactions of CAP+1 (A-->C), a silent beta-globin gene mutation, with other beta-thalassemia mutations and globin gene modifiers in north Indians.
Garewal G; Das R; Awasthi A; Ahluwalia J; Marwaha RK
Eur J Haematol; 2007 Nov; 79(5):417-21. PubMed ID: 17900295
[TBL] [Abstract][Full Text] [Related]
9. [A rare thalassemia intermedia case caused by co-existence of Hb H disease (--(SEA)/-alpha(4.2)) and beta-thalassemia major (beta (CD17A)>T/beta (IVS2-654C)>T): implications for prenatal diagnosis].
Li Q; Li LY; Mo QH
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jan; 28(1):16-9. PubMed ID: 18227017
[TBL] [Abstract][Full Text] [Related]
10. Coinheritance of the different copy numbers of alpha-globin gene modifies severity of beta-thalassemia/Hb E disease.
Sripichai O; Munkongdee T; Kumkhaek C; Svasti S; Winichagoon P; Fucharoen S
Ann Hematol; 2008 May; 87(5):375-9. PubMed ID: 18026953
[TBL] [Abstract][Full Text] [Related]
11. Current status of thalassemia in minority populations in Guangxi, China.
Pan HF; Long GF; Li Q; Feng YN; Lei ZY; Wei HW; Huang YY; Huang JH; Lin N; Xu QQ; Ling SY; Chen XJ; Huang T
Clin Genet; 2007 May; 71(5):419-26. PubMed ID: 17489847
[TBL] [Abstract][Full Text] [Related]
12. Spectrum of hemoglobinopathies in the state of Orissa, India: a ten years cohort study.
Balgir RS
J Assoc Physicians India; 2005 Dec; 53():1021-6. PubMed ID: 16572956
[TBL] [Abstract][Full Text] [Related]
13. Thalassemia.
Cohen AR; Galanello R; Pennell DJ; Cunningham MJ; Vichinsky E
Hematology Am Soc Hematol Educ Program; 2004; ():14-34. PubMed ID: 15561674
[TBL] [Abstract][Full Text] [Related]
14. Interaction of hemoglobin E and several forms of alpha-thalassemia in Cambodian families.
Fucharoen S; Sanchaisuriya K; Fucharoen G; Panyasai S; Devenish R; Luy L
Haematologica; 2003 Oct; 88(10):1092-8. PubMed ID: 14555303
[TBL] [Abstract][Full Text] [Related]
15. Molecular basis of asymptomatic beta-thalassemia major in an African American individual.
Ballas SK; Cai SP; Gabuzda T; Chehab FF
Am J Med Genet; 1997 Mar; 69(2):196-9. PubMed ID: 9056561
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of fractures among the Thalassemia syndromes in North America.
Vogiatzi MG; Macklin EA; Fung EB; Vichinsky E; Olivieri N; Kwiatkowski J; Cohen A; Neufeld E; Giardina PJ
Bone; 2006 Apr; 38(4):571-5. PubMed ID: 16298178
[TBL] [Abstract][Full Text] [Related]
17. The molecular pathology of beta-thalassemia in Turkey: the Boğaziçi university experience.
Basak AN
Hemoglobin; 2007; 31(2):233-41. PubMed ID: 17486506
[TBL] [Abstract][Full Text] [Related]
18. Epidemiologic and clinical characteristics of nontransfusion-dependent thalassemia in the United States.
Vichinsky E; Cohen A; Thompson AA; Giardina PJ; Lal A; Paley C; Cheng WY; McCormick N; Sasane M; Qiu Y; Kwiatkowski JL
Pediatr Blood Cancer; 2018 Jul; 65(7):e27067. PubMed ID: 29637688
[TBL] [Abstract][Full Text] [Related]
19. Thalassemia major in Connecticut: a 20-year study of changing age distribution and survival.
Pearson HA; Rink L; Guiliotis DK
Conn Med; 1994 May; 58(5):259-60. PubMed ID: 8076456
[TBL] [Abstract][Full Text] [Related]
20. Patient age distribution in thalassemia major: changes from 1973 to 1985.
Pearson HA; Guiliotis DK; Rink L; Wells JA
Pediatrics; 1987 Jul; 80(1):53-7. PubMed ID: 3601518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
